Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. (Q34009945)

30 July 2017

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. (English)

1 reference

30 July 2017

0 references

1 reference

17

Bruce D Walker

1 reference

30 July 2017

1

Florencia Pereyra

1 reference

30 July 2017

Christos J Petropoulos

15

object named as

Christos J Petropoulos

1 reference

30 July 2017

Alicja Piechocka-Trocha

8

object named as

Alicja Trocha

1 reference

30 July 2017

16

Eric S Rosenberg

1 reference

30 July 2017

2

Marylyn M Addo

1 reference

30 July 2017

14

Terri Wrin

1 reference

30 July 2017

9

Rachel Rosenberg

1 reference

30 July 2017

6

Almas Rathod

1 reference

30 July 2017

11

Peggy Ueda

1 reference

30 July 2017

5

Toshiyuki Miura

1 reference

30 July 2017

3

Daniel E Kaufmann

1 reference

30 July 2017

Yang Liu

4

1 reference

30 July 2017

Brett Baker

7

1 reference

30 July 2017

Elizabeth Mackey

10

1 reference

30 July 2017

Zhigang Lu

12

1 reference

30 July 2017

Daniel Cohen

13

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

Journal of Infectious Diseases

30 July 2017

1 reference

30 July 2017

197

1 reference

30 July 2017

563-571

1 reference

30 July 2017

4

1 reference

Long-term HIV-1 infection without immunologic progression

30 July 2017

1 reference

Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma

21 January 2018

1 reference

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates

21 January 2018

1 reference

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy

21 January 2018

1 reference

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

21 January 2018

1 reference

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment

21 January 2018

1 reference

Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations

21 January 2018

1 reference

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

21 January 2018

1 reference

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

21 January 2018

1 reference

An HIV vaccine--evolving concepts

21 January 2018

1 reference

Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities

21 January 2018

1 reference

CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research

21 January 2018

1 reference

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

21 January 2018

1 reference

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

21 January 2018

1 reference

Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children

21 January 2018

1 reference

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

21 January 2018

1 reference

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

21 January 2018

1 reference

HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication

21 January 2018

1 reference

Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes

21 January 2018

1 reference

Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes

21 January 2018

1 reference

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

21 January 2018

1 reference

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

21 January 2018

1 reference

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

21 January 2018

1 reference

Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1

21 January 2018

1 reference

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

21 January 2018

1 reference

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy

21 January 2018

1 reference

HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity

21 January 2018

1 reference

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

21 January 2018

1 reference

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

21 January 2018

1 reference

Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/526786

1 reference

30 July 2017

1 reference